N-(TERT-BUTYLCARBAMOYL)-5-CYANO-2-((4'-(DIFLUOROMETHOXY)-[1,1'-BIPHENYL]-3-YL)OXY)BENZENESULFONAMIDE, 95%, 25mg

7-Bromo-4-methoxyindole, 95.0%, 100mg

4-Boc-7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 100mg

Bis(2,4-pentanedionato)bis(2-propanolato)titanium(IV) (75% in Isopropyl Alcohol)25g

3-(3-Fluorophenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine, 95.0%, 1g

(1R)-1-(3-METHYLPHENYL)PROPYLAMINE, 95.0%, 250mg

2,2,2-Trifluoroacetic acid compound with 7-azaspiro[3.5]nonane-2-carboxylic acid (1:1), 98%, 500mg

N-(5-((4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)((4-methyl-3-(5-(thiophen-2-yl)nicotinamido)benzoyl)oxy)carbamoyl)-2-methylphenyl)-5-(thiophen-2-yl)nicotinamide, 97%, 50mg

2-(3,5-dimethylisoxazol-4-yl)ethanol, 95.0%, 1g

9H-Fuoroene-9-carboxylic acid, 95.0%, 100g

1-(2-BROMOPHENYL)-3-(4-CYANO-1H-BENZO[D][1,2,3]TRIAZOL-7-YL)UREA, 97%, 10mg

2-Acetamido-3-(1H-imidazol-4-yl)propanoic acid hydrate, 95.0%, 25g

tert-Butyl (2-(hydroxymethyl)pyridin-3-yl)carbamate, 95.0%, 10g